Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+2.77%
adds when stocks drop
when a holding falls −10%+
Middle response
-3.36%
baseline attrition
Rally response
+0.09%
adds into rallies
when a holding rises +10%+
Top positions · 7
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| SIONSionna Therapeutics, Inc | $99M | 28.3% | +283.3% | 1.3 yr |
| IMNMImmunome, Inc. | $79M | 22.5% | +225.0% | 1.5 yr |
| ZBIOZenas BioPharma, Inc. | $77M | 21.8% | +147.5% | 1.5 yr |
| CMPXCompass Therapeutics, In | $41M | 11.7% | +178.4% | 1.5 yr |
| BBOTBridgeBio Oncology Thera | $24M | 6.7% | — | 0.8 yr |
| UPBUpstream Bio, Inc. | $22M | 6.3% | +47.1% | 1.5 yr |
| CAMPCAMP4 Therapeutics Corpo | $10M | 2.7% | +10.3% | 1.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+0.0pp$352M
Country
US100.0%+0.0pp
Top 5: 91.0% · Top 10: 100.0% · Top 25: 100.0%
Winners
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| SION | $26M | +0.07B | 283.3% |
| IMNM | $32M | +0.07B | 225.0% |
| ZBIO | $30M | +0.04B | 147.5% |
| CMPX | $15M | +0.03B | 178.4% |
| UPB | $15M | +0.01B | 47.1% |
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Top buys this quarter · 0
No buys this quarter
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $352M | 7 | +159.47% | +17.59% | +141.88% | -0.03B |
| 2025-12-31 | $507M | 7 | +143.54% | +17.72% | +125.82% | +0.00B |
| 2025-09-30 | $328M | 7 | +68.30% | +8.12% | +60.18% | +0.03B |
| 2025-06-30 | $177M | 6 | +33.01% | +10.78% | +22.24% | +0.00B |
| 2025-03-31 | $133M | 6 | -29.53% | -4.27% | -25.27% | +0.03B |
| 2024-12-31 | $139M | 5 | — | — | — | — |